Nuveen Asset Management, LLC Bionano Genomics, Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.06 - $1.97 $862,324 - $1.6 Million	813,514 Added 87.6%	1,742,190 $1.93 Million
Q4 2022 Feb 14, 2023	SELL	$1.4 - $25.4 $165,982 - $3.01 Million	-118,559 Reduced 11.32%	928,676 $1.36 Million
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $1,696 - $169,668	-4,713 Reduced 0.45%	1,047,235 $1.92 Million
Q2 2022 Aug 15, 2022	BUY	$12.3 - $27.3 $2.46 Million - $5.46 Million	199,817 Added 23.45%	1,051,948 $1.45 Million
Q1 2022 May 16, 2022	SELL	$16.6 - $32.3 $3.01 Million - $5.86 Million	-181,576 Reduced 17.57%	852,131 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$29.9 - $61.2 $35.9 Million - $73.4 Million	-1,199,440 Reduced 53.71%	1,033,707 $3.09 Million
Q3 2021 Nov 12, 2021	SELL	$51.4 - $68.2 $40.6 Million - $53.9 Million	-790,633 Reduced 26.15%	2,233,147 $12.3 Million
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $133 Million - $254 Million	3,023,780 New	3,023,780 $22.2 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $63.8M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.